Shares Of Micro Cap Biotech Surging On Acquisition Of Exclusive Worldwide Rights to Phase III TLR5 Agonist
12 Fevereiro 2025 - 12:40PM
AllPennyStocks.com
Today was a big day for one small cap biotech
company. The company announced that they had acquired worldwide
exclusive license rights to a late-stage Toll-like Receptor 5
(TLR5)...
To read the full story on AllPennyStocks.com, click
here.
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025